IRD
Opus Genetics Inc.
$1.64
-$0.02(-1.20%)
41
Overall
--
Value
41
Tech
--
Quality
Market Cap
$91.06M
Volume
224.32K
52W Range
$0.65 - $1.75
Target Price
$6.67
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | -- | -- | $589.0K | $39.9M | $19.0M | $11.0M | ||
| Total Revenue | -- | -- | $589.0K | $39.9M | $19.0M | $11.0M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | -- | -- | $589.0K | $39.9M | $19.0M | $11.0M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $-4.2M | $20.0M | $23.3M | $21.6M | $29.6M | $73.1M | ||
| Research & Development | $2.4M | $17.1M | $15.2M | $14.4M | $17.7M | $26.9M | ||
| Research Expense | $2.4M | $17.1M | $15.2M | $14.4M | $17.7M | $26.9M | ||
| Selling, General & Administrative | $1.8M | $2.8M | $8.1M | $7.3M | $12.0M | $18.2M | ||
| General & Administrative Expenses | $1.8M | $2.8M | $8.1M | $7.3M | $12.0M | $18.2M | ||
| Salaries & Wages | $-308.0K | -- | $108.0K | $154.0K | $3.5M | $3.4M | ||
| Depreciation & Amortization | $-3.0K | $8.0K | $4.0K | $4.0K | $6.0K | -- | ||
| Depreciation & Amortization | $-3.0K | $8.0K | $4.0K | $4.0K | $6.0K | -- | ||
| Amortization | $-1.0M | $873.0K | -- | -- | -- | -- | ||
| Other Operating Expenses | $-200.9K | $54.0K | $116.0K | $39.0K | $36.0K | $140.0K | ||
| OPERATING INCOME | ||||||||
| Operating income | $-4.2M | $-20.0M | $-22.7M | $18.2M | $-10.6M | $-62.1M | ||
| EBITDA | $-3.6M | $-17.8M | $-56.7M | $18.2M | $-10.0M | $-57.5M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $1.4M | $6.8M | $2.0K | $9.0K | -- | -- | ||
| Intinc | $313.7K | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-1.4M | $-6.8M | $-2.0K | $-9.0K | $1.3M | -- | ||
| Gain on Sale of Securities | $-499.0K | $-1.5M | $-33.8M | $-170.0K | $80.0K | $72.0K | ||
| Other Income/Expense | $567.0K | $-2.2M | $34.0M | $-14.0K | $-1.9M | $-4.5M | ||
| Other Special Charges | $-68.0K | $3.7M | $-157.0K | $-14.0K | $1.8M | $4.5M | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-4.8M | $-17.8M | $-56.7M | $18.2M | $-10.0M | $-57.5M | ||
| Pre-Tax Income | $-6.2M | $-24.6M | $-56.7M | $18.2M | $-10.0M | $-57.5M | ||
| INCOME TAX | ||||||||
| Tax Provision | -- | -- | -- | $315.0K | $12.0K | -- | ||
| NET INCOME | ||||||||
| Net Income | $-6.2M | $-24.6M | $-56.7M | $17.9M | $-10.0M | $-57.5M | ||
| Net Income (Continuing Operations) | $-6.2M | $-24.6M | $-56.7M | $17.9M | $-10.0M | $-57.5M | ||
| Net Income (Discontinued Operations) | $-6.2M | $-24.6M | $-56.7M | $17.9M | $-10.0M | $-57.5M | ||
| Net Income (Common Stockholders) | $-6.2M | $-24.6M | $-56.7M | $17.9M | $-10.0M | $-57.5M | ||
| Normalized Income | -- | -- | $-44.8M | -- | -- | $-57.0M | ||
| TOTALS | ||||||||
| Total Expenses | $-4.2M | $20.0M | $23.3M | $21.6M | $29.6M | $73.1M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $990.0K | $4.7M | $14.9M | $19.9M | $21.6M | $26.7M | ||
| Average Shares Outstanding (Diluted) | $990.3K | $4.7M | $14.9M | $20.6M | $21.6M | $26.7M | ||
| Shares Outstanding | $1.0M | $10.9M | $59.9M | $20.9M | $24.8M | $45.5M | ||
| Basic EPS | -- | $-5.28 | $-3.82 | $0.90 | $-0.46 | $-2.15 | ||
| Basic EPS (Continuing Operations) | -- | $-5.28 | $-3.82 | $0.90 | $-0.46 | $-2.15 | ||
| Diluted EPS | $-8.72 | $-5.28 | $-3.82 | $0.87 | $-0.46 | $-2.15 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-3.82 | $0.87 | $-0.46 | $-2.15 | ||
| OTHER METRICS | ||||||||
| Gain On Sale Of P P E | $-9.6K | -- | -- | -- | -- | -- | ||
| Other Gand A | $1.8M | $2.8M | $8.1M | $7.3M | $12.0M | $18.2M | ||
| Rent And Landing Fees | $1.8M | $54.0K | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IRD | $1.64 | -1.2% | 224.32K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |